Searched for
WEGOVY PATENT CASE
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...- Mounjaro sales dip amid price war as semaglutide generics gain groundMounjaro, the star pharmaceutical from Eli Lilly, is experiencing a downturn in sales across India. This slump can be attributed to competi...
- Rs 12,000 crore magic pill race begins to shrink India's pot bellies. Which pharma stocks will win GLP-1 war?India's GLP-1 market is set for a massive boom. Following patent expiry, generic versions of semaglutide are launching at significantly low...
- Table 2.0: Restaurants absorb 'Ozempic effect' for weight-loss drug consumersIndian restaurants are adapting to a growing consumer base using weight-loss medications like Ozempic and Mounjaro by introducing "Size O" ...
- 2025 in the rearview: A year of tumult and triumphIndia's economy in 2025 faced challenges from US tariffs and foreign investor exits. Despite these, domestic demand and reforms fueled stro...
- Delhi HC refuses to stay order allowing Dr Reddy's to export semaglutideThe Delhi High Court has taken a firm stand by rejecting Novo Nordisk's plea to pause a prior ruling. This decision empowers Dr Reddy's Lab...
- Delhi HC allows Dr. Reddy’s to export weight-loss drug semaglutide, calls Novo Nordisk’s case ‘weak’The Delhi High Court declined to stay a single-judge order allowing Dr. Reddy's to export its semaglutide, observing Novo Nordisk's appeal ...
- Delhi HC allows Sun Pharma to manufacture, export its own weight loss drugThe Delhi High Court has allowed Sun Pharma to manufacture and export its version of semaglutide, the diabetes and anti-obesity drug made b...
- HC lets Dr Reddy's Laboratories export Semaglutide, blocks India sales till March '26The Delhi High Court has permitted Dr Reddy's Laboratories to produce and export its version of the diabetes and anti-obesity drug semaglut...
- Natco Pharma sues Novo Nordisk in generic drug pushThe lawyers representing Natco Pharma informed the court that over the past few months it had approached Novo Nordisk to communicate on its...
- Food Chained: How weight-loss drugs are changing India’s eating habits and forcing restaurants to take noteNew diabetes and obesity drugs, like Mounjaro and Ozempic, are changing people's relationships with food. While these drugs help control di...
- When people slim down, businesses bulk upThe rising popularity of weight-loss drugs like Mounjaro and Wegovy is poised to create new opportunities for various sectors beyond pharma...
- Obesity lab: India becomes ground zero for weight-loss drug raceIndia is emerging as a key player in the global weight management industry, driven by a rising obesity crisis and the impending patent expi...
- Zydus Life's plans for cancer biosimilar hit a legal hurdleThe Delhi High Court has granted an interim injunction against Zydus Lifesciences, an Ahmedabad-based drug maker, following a patent infrin...
- Dr Reddy’s, Sun, Cipla and Biocon look to recreate Ozempic magic in IndiaDoctors say patients come with specific queries regarding weight-loss drugs, which have become both the first preference and the last resor...
Load More
